Pharmaceuticals News

Oxford, UK – 16th April 2026 - Alethio Therapeutics, a biopharmaceutical company developing novel treatments for myeloproliferative neoplasms (MPN), today announced the unveiling of ATX‑011, a...

Roquette réalise avec succès son émission obligataire hybride, pour un montant de 600 millions d'euros Lille, le 16 avril 2026 - Roquette, un leader mondial des ingrédients d'origine végétale et un...

Roquette Successfully Prices its Hybrid Notes Issuance for an Amount of 600 million Euros Lille, 16 April, 2026 – Roquette, a global leader of plant-based ingredients and pharmaceutical excipients...

Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure

STORM Therapeutics announces a $56 million Series C financing to support the advancement of STC-15 in a Phase 2 study.

Lehi, Utah, April 16, 2026 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today...

TME Pharma publie les résultats de l'essai GLORIA sur la trithérapie NOX-A12 dans *Nature Communications* ; des discussions en vue d'un partenariat sont en

TME Pharma publishes NOX-A12 triple therapy GLORIA trial data in Nature Communications; partnership talks ongoing.

EUROBIO SCIENTIFIC SIGNS DEFINITIVE AGREEMENT TO ACQUIRE CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acquisition of CareDx’s ‘lab products’ portfolio creates new opportunities for growth and innovation...

Pharming Group N.V. 2026 Annual General Meeting to be be held on Thursday May 28, 2026, at 14:00 CET. Meeting documents available on website Pharming.com.